These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 33602882)
1. Centromere protein U enhances the progression of bladder cancer by promoting mitochondrial ribosomal protein s28 expression. Liu BB; Ma T; Sun W; Gao WY; Liu JM; Li LQ; Li WY; Wang S; Guo YY Korean J Physiol Pharmacol; 2021 Mar; 25(2):119-129. PubMed ID: 33602882 [TBL] [Abstract][Full Text] [Related]
2. Centromere protein U is a potential target for gene therapy of human bladder cancer. Wang S; Liu B; Zhang J; Sun W; Dai C; Sun W; Li Q Oncol Rep; 2017 Aug; 38(2):735-744. PubMed ID: 28677729 [TBL] [Abstract][Full Text] [Related]
3. Centromere protein U (CENPU) enhances angiogenesis in triple-negative breast cancer by inhibiting ubiquitin-proteasomal degradation of COX-2. Pan T; Zhou D; Shi Z; Qiu Y; Zhou G; Liu J; Yang Q; Cao L; Zhang J Cancer Lett; 2020 Jul; 482():102-111. PubMed ID: 31705927 [TBL] [Abstract][Full Text] [Related]
4. The effect of centromere protein U silencing by lentiviral mediated RNA interference on the proliferation and apoptosis of breast cancer. Lin SY; Lv YB; Mao GX; Chen XJ; Peng F Oncol Lett; 2018 Nov; 16(5):6721-6728. PubMed ID: 30405814 [TBL] [Abstract][Full Text] [Related]
5. Centromere protein U promotes cell proliferation, migration and invasion involving Wnt/β-catenin signaling pathway in non-small cell lung cancer. Zhang Q; Li YD; Zhang SX; Shi YY Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7768-7777. PubMed ID: 30536323 [TBL] [Abstract][Full Text] [Related]
6. Centromere protein U facilitates metastasis of ovarian cancer cells by targeting high mobility group box 2 expression. Li H; Zhang H; Wang Y Am J Cancer Res; 2018; 8(5):835-851. PubMed ID: 29888106 [TBL] [Abstract][Full Text] [Related]
7. [Centromere protein U is highly expressed in colorectal cancer and associated with a poor long-term prognosis]. Zhang X; Yang Z; Hu Q; Zuo L; Song X; Geng Z; Li J; Wang Y; Ge S; Hu J Nan Fang Yi Ke Da Xue Xue Bao; 2022 Aug; 42(8):1198-1204. PubMed ID: 36073219 [TBL] [Abstract][Full Text] [Related]
8. Centromere protein U (CENPU) promotes gastric cancer cell proliferation and glycolysis by regulating high mobility group box 2 (HMGB2). Deng T; Jiang X; He Z; Cai M; Chen C; Xu Z Bioengineered; 2021 Dec; 12(2):10194-10202. PubMed ID: 34872447 [TBL] [Abstract][Full Text] [Related]
9. Centromere protein U expression promotes non-small-cell lung cancer cell proliferation through FOXM1 and predicts poor survival. Wang X; Chen D; Gao J; Long H; Zha H; Zhang A; Shu C; Zhou L; Yang F; Zhu B; Wu W Cancer Manag Res; 2018; 10():6971-6984. PubMed ID: 30588102 [TBL] [Abstract][Full Text] [Related]
10. Reduced CENPU expression inhibits lung adenocarcinoma cell proliferation and migration through PI3K/AKT signaling. Li J; Wang ZG; Pang LB; Zhang RH; Wang YY Biosci Biotechnol Biochem; 2019 Jun; 83(6):1077-1084. PubMed ID: 30849291 [TBL] [Abstract][Full Text] [Related]
11. Short communication: A splice site mutation in CENPU is associated with recessive embryonic lethality in Holstein cattle. Hozé C; Escouflaire C; Mesbah-Uddin M; Barbat A; Boussaha M; Deloche MC; Boichard D; Fritz S; Capitan A J Dairy Sci; 2020 Jan; 103(1):607-612. PubMed ID: 31733857 [TBL] [Abstract][Full Text] [Related]
12. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1. Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637 [TBL] [Abstract][Full Text] [Related]
13. lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer. Qiu F; Zhang MR; Zhou Z; Pu JX; Zhao XJ J Cell Biochem; 2019 Jun; 120(6):10821-10829. PubMed ID: 30672010 [TBL] [Abstract][Full Text] [Related]
14. A new PKCα/β/TBX3/E-cadherin pathway is involved in PLCε-regulated invasion and migration in human bladder cancer cells. Du HF; Ou LP; Yang X; Song XD; Fan YR; Tan B; Luo CL; Wu XH Cell Signal; 2014 Mar; 26(3):580-93. PubMed ID: 24316392 [TBL] [Abstract][Full Text] [Related]
15. Derivatives of the yeast mitochondrial ribosomal protein MrpS28 replace ribosomal protein S15 as functional components of the Escherichia coli ribosome. Li Y; Huff MO; Hanic-Joyce PJ; Ellis SR J Mol Biol; 1993 Oct; 233(4):606-14. PubMed ID: 8411168 [TBL] [Abstract][Full Text] [Related]
16. Down-regulation of CIT can inhibit the growth of human bladder cancer cells. Liu Z; Yan H; Yang Y; Wei L; Xia S; Xiu Y Biomed Pharmacother; 2020 Apr; 124():109830. PubMed ID: 31972359 [TBL] [Abstract][Full Text] [Related]
17. Activation of EZH2 and SUZ12 Regulated by E2F1 Predicts the Disease Progression and Aggressive Characteristics of Bladder Cancer. Lee SR; Roh YG; Kim SK; Lee JS; Seol SY; Lee HH; Kim WT; Kim WJ; Heo J; Cha HJ; Kang TH; Chung JW; Chu IS; Leem SH Clin Cancer Res; 2015 Dec; 21(23):5391-403. PubMed ID: 26268246 [TBL] [Abstract][Full Text] [Related]
18. Tumor progression and expression of matrix metalloproteinase-2 (MMP-2) mRNA by human urinary bladder cancer cells. Hamasaki T; Hattori T; Kimura G; Nakazawa N Urol Res; 1998; 26(6):371-6. PubMed ID: 9879815 [TBL] [Abstract][Full Text] [Related]
19. ZSCAN16 promotes proliferation, migration and invasion of bladder cancer via regulating NF-kB, AKT, mTOR, P38 and other genes. Li X; Shang D; Shen H; Song J; Hao G; Tian Y Biomed Pharmacother; 2020 Jun; 126():110066. PubMed ID: 32172065 [TBL] [Abstract][Full Text] [Related]
20. Circ0001429 regulates progression of bladder cancer through binding miR-205-5p and promoting VEGFA expression. Cao W; Zhao Y; Wang L; Huang X Cancer Biomark; 2019; 25(1):101-113. PubMed ID: 30909190 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]